Mass spectrometry (MS) enjoyed a very good 2014 as revenues exceeded 7%, a nice improvement from 2013, led by LC/MS systems, both quadrupole and time-of-flight (TOF) MS instruments. On the other hand, demand for portable, in-field and magnetic-sector MS instruments was anemic, growing less than 3%. This year, the total MS market is expected to […]
The life science (LS) market consists of 14 distinct technology categories and is the largest of all analytical-instrument markets, including aftermarket and service revenues. In this year’s forecast issue, the LS category also includes capillary electrophoresis, which was previously counted as part of the separations market. In 2014, the LS market increased 5.9% to $11.8 […]
The chromatography market increased to nearly $8.17 billion in 2014 on 3.9% growth. This segment’s forecast excludes capillary electrophoresis, which has been moved to the life science segment (see page 2). Also, clinical HPLC has been added as a subsegment. Aftermarket and service demand grew 4.5% and 5.1%, respectively, last year, while demand for initial […]
Merck KGaA and Sigma-Aldrich Consolidation continued in the lab-products market, as less than a year after Thermo Fisher Scientific’s purchase of Life Technologies (see IBO 2/15/14), Merck KGaA announced a $17 billion deal to buy Sigma-Aldrich (see IBO 9/30/14). The deal highlights the importance of scale and diversification and transforms Merck/EMD Millipore into a major […]
A More Focused Approach As economic headwinds in China, industrial and selected government markets continued in 2014, several analytical-instrument and lab-product companies took steps to focus on a narrower set of businesses and product lines, in some cases, divesting assets and, in other cases, consolidating their positions. Among the year’s most prominent product-line exits were […]
Cambridge, UK and Vienna, Austria 1/8/15—Horizon Discovery has agreed to acquire Haplogen Genomics for £6.0 million ($9.1 million = £0.66 = $1) in cash and stock, and potential earn-out payments. Haplogen’s high-throughput platform generates genetically defined human cell lines at a lower cost by using haploid cells. In 2014, Haplogen generated €688,000 ($917,000 = €0.75 […]
Shanghai, China 1/9/15—WuXi PharmaTech, a provider of lab and manufacturing services for drug and medical-device R&D, has acquired NextCODE Health for $65 million in cash. NextCODE provides a genome sequence–analysis platform for clinicians and researchers, including access to the largest clinical-genetics–reference database, creating a system developed at population scale, according to WuXi. “This new venture […]
Hilden, Germany and Beverly, MA 1/11/15—QIAGEN has acquired Enzymatics’ Enzyme Solutions Unit for an undisclosed amount. The Unit develops, manufactures and is an OEM supplier of enzymes for genetic-analysis technologies, including NGS. The acquisition is expected to add $20 million of incremental net sales in 2015 and be accretive by $0.01 to adjusted diluted EPS. […]
San Diego, CA 1/12/15; San Francisco, CA 1/12/15; Washington, DC 1/12/15—At the annual JP Morgan Healthcare Conference, Illumina announced that its 2014 revenues grew 20%, following a 32% increase in the fourth quarter to $512 million. The company forecasts 2015 revenues to increase 20% and non-GAAP EPS of $3.12–$3.18. In addition, Illumina announced four new […]
The instrument industry performed well in 2014, a welcome rebound from a lackluster 2013. Although a fair degree of uncertainty reigned, a number of positive developments helped make the year a success. The most important development was the improvement of the US economy, which steadily accelerated. China also turned in good economic progress that was […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
